Search

Author/Creator El Raziky, M.

1. Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis. Issue 2 (27th October 2016)

Authors:
El Raziky, M.; Gamil, M.; Ashour, M. K.; Sameea, E. A.; Doss, W.; Hamada, Y.; Van Dooren, G.; DeMasi, R.; Keim, S.; Lonjon‐Domanec, I.; Hammad, R.; Hashim, M. S.; Hassany, M.; Waked, I.
Journal:
Journal of viral hepatitis
Issue:
Volume 24:Issue 2(2017)
Page Start:
102
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Sofosbuvir‐based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt. Issue 5 (9th January 2017)

Authors:
Elsharkawy, A.; Fouad, R.; El Akel, W.; El Raziky, M.; Hassany, M.; Shiha, G.; Said, M.; Motawea, I.; El Demerdash, T.; Seif, S.; Gaballah, A.; El Shazly, Y.; Makhlouf, M. A. M.; Waked, I.; Abdelaziz, A. O.; Yosry, A.; El Serafy, M.; Thursz, M.; Doss, W.; Esmat, G.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 45:Issue 5(2017)
Page Start:
681
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The adverse effects of interferon‐free regimens in 149 816 chronic hepatitis C treated Egyptian patients. Issue 9 (5th March 2018)

Authors:
Attia, D.; El Saeed, K.; Elakel, W.; El Baz, T.; Omar, A.; Yosry, A.; Elsayed, M. H.; Said, M.; El Raziky, M.; Anees, M.; Doss, W.; El Shazly, Y.; Wedemeyer, H.; Esmat, G.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 9(2018)
Page Start:
1296
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗